Table 2.
Indications for Gd-DOTA-MRI and unenhanced-MRI examinations, evaluable safety population
| MRI study area (n,%) | Gd-DOTA-MRIa (n = 70) | Unenhanced MRIa (n = 44) | Totala (n = 114) | P-values (Fisher’s exact test) |
|---|---|---|---|---|
| Body (abdomen/thorax) | 37 (52.9 %) | 13 (29.5 %) | 50 (43.9 %) | |
| Kidney | 23 (32.9 %) | 10 (22.7 %) | 33 (28.9 %) | P = 0.134 |
| Pelvis | 8 (11.4 %) | 1 (2.3 %) | 9 (7.9 %) | |
| Limbs | 4 (5.7 %) | 0 (0.0 %) | 4 (3.5 %) | |
| Liver | 0 (0.0 %) | 2 (4.5 %) | 2 (1.8 %) | |
| Pancreas | 1 (1.4 %) | 0 (0.0 %) | 1 (0.9 %) | |
| Heart | 1 (1.4 %) | 0 (0.0 %) | 1 (0.9 %) | |
| Angiography | 20 (28.6 %) | 5 (11.4 %) | 25 (21.9 %) | |
| Renal | 15 (21.4 %) | 4 (9.1 %) | 19 (16.7 %) | P = 0.781 |
| Carotid | 1 (1.4 %) | 1 (2.3 %) | 2 (1.8 %) | |
| Aorto-iliac | 2 (2.9 %) | 0 (0.0 %) | 2 (1.8 %) | |
| Other | 2 (2.9 %) | 0 (0.0 %) | 2 (1.8 %) | |
| Musculoskeletal system (bones/joints) | 2 (2.9 %) | 14 (31.8 %) | 16 (14.0 %) | – |
| Central nervous system | 1 (1.4 %) | 9 (20.5 %) | 10 (8.8 %) | |
| Brain | 1 (1.4 %) | 7 (15.9 %) | 8 (7.0 %) | P = 1.000 |
| Head/neck | 0 (0.0 %) | 2 (4.5 %) | 2 (1.8 %) | |
| Other indications | 10 (14.3 %) | 6 (13.6 %) | 16 (14.0 %) | – |
aA patient with multiple indications is counted several times